PET in Multiple Myeloma: Evidences, Applications and Perspectives
2026-07-09 09:00 - 2026-07-10 12:30 (Europe/Vienna) | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
More information will come soon.

Register nowRegistration is now open, save yourself a seat! Register now

Learning Objectives

More info will come soon.

Target Audience

More info will come soon.

ProgrammeThe programme will come soon. View the Programme

Faculty

SpeakerSpeaker

SpeakerSpeaker

SpeakerSpeaker

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

NEW Department Package: If you send 5 participants from your department, you will get an additional 6th seat for free for this course. Please get in touch with the ESMIT office if this is of interest to you.

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Trustworthy AI and Human Oversight
2026-09-18 13:30 - 14:30
More info will come soon

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

More info will come soon

Target Audience

More info will come soon

Faculty

SpeakerSpeaker

SpeakerSpeaker

SpeakerModerator

Event Overview

Prostate Cancer Theranostics
2026-09-24 09:00 - 2026-09-25 12:30 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria

With a Little Help of Artificial Intelligence for the Sake of Radiation Protection
2026-11-06 13:30 - 14:30

Biomarker Assessment for an Early Biological Diagnosis of Alzheimer's Disease
2026-11-12 09:00 - 2026-11-13 12:30 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
More information will come soon.

Register nowRegistration is now open, save yourself a seat! Register now

Learning Objectives

More info will come soon.

Target Audience

More info will come soon.

ProgrammeThe programme will come soon. View the Programme

Faculty

SpeakerSpeaker

SpeakerSpeaker

SpeakerSpeaker

Registration Details

Registration FeeCancellation Policy

Course Fee FREE

Course includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Course does NOT include:

Travel to the Venue

Accommodation

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Ring Geometry SPECT/CT System
2026-11-27 13:30 - 14:30

Focus on Benign Thyroid Disease: From Thyroid Nodule to Hyperthyroidism and Immune Disease
2026-12-03 09:00 - 2026-12-04 12:30 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria

Tips and Tricks on Imaging with New CZT SPECT Systems
2026-12-11 13:30 - 14:30

Fundamentals of Research in Imaging and Theranostics – Part 1: Research Design
2026-12-31 00:00 - 23:59 | Online
UEMS EACCME has granted the accreditation of 4 CME credits for this event.

This online course is part of a long line of research methodology which is aimed at providing interested participants with information about the preclinical development and clinical translation, as well as the design, conductance and reporting of clinical research trials, with a specific emphasis on radiopharmaceuticals for both diagnostic and therapeutic applications.

These first two modules will represent part one of the course.

Module 1 will focus on the entire path from preclinical development to clinical translation of an imaging compound, including the preclinical studies needed for the selection of a new candidate for clinical translation, an overview of EU legislation on radiopharmaceuticals for diagnosis and therapy, and the assessment of quality data and non-clinical data (pharmacology, dosimetry and toxicology) for the IMP dossier.

Module 2 will be focused on the design of a proper trial. It will cover: the definition of objectives, aims, endpoints, population, statistical methods and examples of trial design schemes, as well as dosimetry as far as healthy organs and in case of therapy tumour-absorbed dose. It will have a special focus on phase 0, phase 1-2 trial, early clinical phase 0-1-2 and investigator-driven clinical trial.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives:

Learn about:

Preclinical development and clinical translation of radiopharmaceuticals

The legislation on radiopharmaceuticals with a specific focus on the European scenario

Requirements of IMPD for radiopharmaceuticals for imaging agents and theranostic/therapeutic molecules Interpretation of preclinical data to properly design and plan the clinical trial

Phase 0, phase 1 and phase 2 clinical trials with radiopharmaceuticals design

Phase 0, phase 1 and phase 2 clinical trials with radiopharmaceuticals conductance

GMP, GLP and GCP principles

Importance of radioprotection and dosimetric estimates in early phase clinical trials

Target Audience:

Researchers, scientists, nurses, pharmacologists, radiopharmacists, residents and specialists in Nuclear Medicine/Oncology/Radiology who want to understand how clinical trials with radiopharmaceuticals in the early phase are unique and how the corresponding documents and trial design should be appropriately planned.

ProgrammeClick to see the full event programme. View the Programme

Faculty

Paola Anna ErbaUniversità degli Studi di Milano-Bicocca, Italy

Sona BalogovaComenius University, Bratislava, Slovakia

Elisabeth von GuggenbergMedical University Innsbruck, Austria

Martina SolliniVita-Salute San Raffaele University, Milan, Italy

Luigi AlojUniversity of Cambridge, United Kingdom

Meltem OcakIstanbul University, Turkey

Peter LavermanRadboud Universiteit Nijmegen, The Netherlands

Jane SosabowskiQueen Mary, University of London, United Kingdom

Petra KolencUniversity Medical Centre Ljubljana, Slovenia

Clemens DecristoforoMedical University Innsbruck, Austria

Piotr GarnuszekPOLATOM, Warsaw, Poland

Renata MikolajczakPOLATOM, Warsaw, Poland

Theodosia MainaNCSR Demokritos, Athens, Greece

Mark KonijnenbergErasmus MC, Rotterdam, The Netherlands

Registration Details

Registration Fee

Course Fee Free

Event Overview
